Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3221414
Max Phase: Preclinical
Molecular Formula: C38H78NO16P
Molecular Weight: 734.81
Molecule Type: Small molecule
Associated Items:
ID: ALA3221414
Max Phase: Preclinical
Molecular Formula: C38H78NO16P
Molecular Weight: 734.81
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCOCC(COP(=O)(O)OC1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)OC.CCN(CC)CC
Standard InChI: InChI=1S/C32H63O16P.C6H15N/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-43-20-22(42-2)21-44-49(40,41)48-32-29(39)27(37)30(24(19-34)46-32)47-31-28(38)26(36)25(35)23(18-33)45-31;1-4-7(5-2)6-3/h22-39H,3-21H2,1-2H3,(H,40,41);4-6H2,1-3H3/t22?,23-,24-,25-,26+,27-,28-,29-,30-,31-,32?;/m1./s1
Standard InChI Key: YYBLDTXHZKTVJJ-CUEDQKBISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 734.81 | Molecular Weight (Monoisotopic): 734.3854 | AlogP: 1.26 | #Rotatable Bonds: 27 |
Polar Surface Area: 243.52 | Molecular Species: ACID | HBA: 15 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.59 | CX Basic pKa: | CX LogP: 2.18 | CX LogD: -0.20 |
Aromatic Rings: 0 | Heavy Atoms: 49 | QED Weighted: 0.04 | Np Likeness Score: 1.31 |
1. Sevrain CM, Haelters J, Chantome A, Couthon-Gourves H, Girault A, Vandier C, Jaffres P. (2012) Glyco-Phospho-Glycero Ether Lipids (GPGEL): synthesis and evaluation as small conductance Ca2+-activated K+ channel (SK3) inhibitors, 3 (11): [10.1039/C2MD20207G] |
Source(1):